These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 27777011)
1. Variation of the aryl substituent on the piperazine ring within the 4-(piperazin-1-yl)-2,6-di(pyrrolidin-1-yl)pyrimidine scaffold unveils potent, non-competitive inhibitors of the inflammatory caspases. Kent CR; Bryja M; Gustafson HA; Kawarski MY; Lenti G; Pierce EN; Knopp RC; Ceja V; Pati B; Walters DE; Karver CE Bioorg Med Chem Lett; 2016 Nov; 26(22):5476-5480. PubMed ID: 27777011 [TBL] [Abstract][Full Text] [Related]
2. Lazaroids U83836E and U74389G are potent, time-dependent inhibitors of caspase-1. Kawarski M; Hagerman TK; Karver CE Chem Biol Drug Des; 2015 Nov; 86(5):1049-54. PubMed ID: 25871734 [TBL] [Abstract][Full Text] [Related]
3. Non-steroidal Anti-inflammatory Drugs Are Caspase Inhibitors. Smith CE; Soti S; Jones TA; Nakagawa A; Xue D; Yin H Cell Chem Biol; 2017 Mar; 24(3):281-292. PubMed ID: 28238723 [TBL] [Abstract][Full Text] [Related]
4. Small Molecule Active Site Directed Tools for Studying Human Caspases. Poreba M; Szalek A; Kasperkiewicz P; Rut W; Salvesen GS; Drag M Chem Rev; 2015 Nov; 115(22):12546-629. PubMed ID: 26551511 [TBL] [Abstract][Full Text] [Related]
5. Structure-based design, synthesis and evaluation of 2,4-diaminopyrimidine derivatives as novel caspase-1 inhibitors. Patel S; Modi P; Ranjan V; Chhabria M Bioorg Chem; 2018 Aug; 78():258-268. PubMed ID: 29614437 [TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of initiator versus executioner caspases using small peptides containing unnatural amino acids. Vickers CJ; González-Páez GE; Litwin KM; Umotoy JC; Coutsias EA; Wolan DW ACS Chem Biol; 2014 Oct; 9(10):2194-8. PubMed ID: 25079698 [TBL] [Abstract][Full Text] [Related]
7. Single-cell imaging of inflammatory caspase dimerization reveals differential recruitment to inflammasomes. Sanders MG; Parsons MJ; Howard AG; Liu J; Fassio SR; Martinez JA; Bouchier-Hayes L Cell Death Dis; 2015 Jul; 6(7):e1813. PubMed ID: 26158519 [TBL] [Abstract][Full Text] [Related]
8. A Fluorescence-Polarization-Based Lipopolysaccharide-Caspase-4 Interaction Assay for the Development of Inhibitors. An J; Kim SY; Yang EG; Chung HS Molecules; 2022 Apr; 27(8):. PubMed ID: 35458656 [TBL] [Abstract][Full Text] [Related]
9. Cytoprotective effect of selective small-molecule caspase inhibitors against staurosporine-induced apoptosis. Wu J; Wang Y; Liang S; Ma H Drug Des Devel Ther; 2014; 8():583-600. PubMed ID: 24920883 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological caspase inhibitors: research towards therapeutic perspectives. Kudelova J; Fleischmannova J; Adamova E; Matalova E J Physiol Pharmacol; 2015 Aug; 66(4):473-82. PubMed ID: 26348072 [TBL] [Abstract][Full Text] [Related]
11. Application of the Movable Type Free Energy Method to the Caspase-Inhibitor BindingAffinity Study. Xue S; Liu H; Zheng Z Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569580 [TBL] [Abstract][Full Text] [Related]
12. New Caspase-1 inhibitor by scaffold hopping into bio-inspired 3D-fragment space. Brethon A; Chantalat L; Christin O; Clary L; Fournier JF; Gastreich M; Harris CS; Isabet T; Pascau J; Thoreau E; Roche D; Rodeschini V Bioorg Med Chem Lett; 2017 Dec; 27(24):5373-5377. PubMed ID: 29157864 [TBL] [Abstract][Full Text] [Related]
13. Carboxylate isosteres for caspase inhibitors: the acylsulfonamide case revisited. Adriaenssens Y; Jiménez Fernández D; Vande Walle L; Elvas F; Joossens J; Lambeir A; Augustyns K; Lamkanfi M; Van der Veken P Org Biomol Chem; 2017 Sep; 15(35):7456-7473. PubMed ID: 28837200 [TBL] [Abstract][Full Text] [Related]
15. Pyroptotic cell death defends against intracellular pathogens. Jorgensen I; Miao EA Immunol Rev; 2015 May; 265(1):130-42. PubMed ID: 25879289 [TBL] [Abstract][Full Text] [Related]
16. Exploring the ring potential of 2,4-diaminopyrimidine derivatives towards the identification of novel caspase-1 inhibitors in Alzheimer's disease therapy. Kumi RO; Soremekun OS; Issahaku AR; Agoni C; Olotu FA; Soliman MES J Mol Model; 2020 Mar; 26(4):68. PubMed ID: 32130533 [TBL] [Abstract][Full Text] [Related]
18. The potential for caspases in drug discovery. MacKenzie SH; Schipper JL; Clark AC Curr Opin Drug Discov Devel; 2010 Sep; 13(5):568-76. PubMed ID: 20812148 [TBL] [Abstract][Full Text] [Related]
19. Identification of FDA-approved drugs as novel allosteric inhibitors of human executioner caspases. Krishna Deepak RNV; Abdullah A; Talwar P; Fan H; Ravanan P Proteins; 2018 Nov; 86(11):1202-1210. PubMed ID: 30194780 [TBL] [Abstract][Full Text] [Related]